| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| Fc epsilon RI alpha | HOT FCA-C52H9 | Cynomolgus Fc epsilon RI alpha Protein, His Tag (SPR verified) | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $310.00 100ug | |
| Fc epsilon RI alpha | HOT FCA-H5228 | Human Fc epsilon RI alpha Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $325.00 100ug | |
| Fc epsilon RI alpha | HOTAvitag FCA-H82E3 | Biotinylated Human Fc epsilon RI alpha Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $470.00 25ug | |
| Fc epsilon RI alpha | HOT FCA-H5259 | Human Fc epsilon RI alpha Protein, Fc Tag (MALS & BLI verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $310.00 100ug | |
| Fc epsilon RI alpha | Cynomolgus Fc epsilon RI alpha Protein, Fc Tag (BLI verified) | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $310.00 100ug | ||
| Fc epsilon RI alpha | Mouse Fc epsilon RI alpha Protein, Fc Tag | Mouse | HEK293 | ![]() | SDS-PAGE | $300.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Lesigercept | YH-35324; GI-301 | Phase 2 Clinical | Yuhan Corp | Chronic Urticaria; Hypersensitivity; Immune System Diseases; Urinary Tract Infections; Urticaria | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Benzylpenicilloyl Polylysine | Approved | Allerquest Llc | Pre-pen | United States | Anaphylaxis; Diagnostic agents | Allerquest Inc | 1974-07-25 | Anaphylaxis; Diagnostic agents | Details |